source
- AstraZeneca signs up to $1.7 billion R&D pact with China’s CSPC, marking second deal in six monthsAstraZeneca announced a new research collaboration with Chinese partner CSPC, valued at up to $1.7 billion. The agreement follows a previous large biobucks deal signed less than six months earlier…
- FDA grants first clearance for patient-facing LLM diabetes app, marking historic step for AI in medical softwareUpDoc's diabetes management app received FDA clearance, the first for software that uses patient-facing large language models. The app is designed to help patients follow treatment plans set by th…